RESEARCHER PROFILE

Philippe Devillier

← Back to Université de Versailles Saint-Quentin-en-Yvelines

P

Université de Versailles Saint-Quentin-en-Yvelines

Asthma and respiratory diseasesAllergic Rhinitis and SensitizationChronic Obstructive Pulmonary Disease (COPD) ResearchFood Allergy and Anaphylaxis ResearchInhalation and Respiratory Drug Delivery

Philippe Devillier works in Asthma and respiratory diseases, Allergic Rhinitis and Sensitization, Chronic Obstructive Pulmonary Disease (COPD) Research, Food Allergy and Anaphylaxis Research, Inhalation and Respiratory Drug Delivery. Recorded institutional associations include Inserm, Vilnius University, Université de Versailles Saint-Quentin-en-Yvelines.

596Publications
13,375Citations
63H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

    2012 · 626 citations
  2. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence

    2019 · 609 citations
  3. Intranasal drug delivery: An efficient and non-invasive route for systemic administration

    2012 · 428 citations
  4. Mild asthma: an expert review on epidemiology, clinical characteristics and treatment recommendations

    2007 · 247 citations
  5. Metabolomics of exhaled breath in critically ill COVID-19 patients: A pilot study

    2020 · 215 citations
  6. Impact of Allergic Rhinitis Symptoms on Quality of Life in Primary Care

    2012 · 205 citations
  7. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

    2015 · 201 citations
  8. Sublingual immunotherapy provides long‐term relief in allergic rhinitis and reduces the risk of asthma: A retrospective, real‐world database analysis

    2017 · 184 citations
  9. Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber

    2009 · 176 citations
  10. Integrated care pathways for airway diseases (AIRWAYS-ICPs)

    2014 · 174 citations
  11. Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care

    2013 · 167 citations
  12. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

    2018 · 162 citations
  13. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

    2016 · 160 citations
  14. Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomy.

    1996 · 158 citations
  15. Characterization of Neurokinin Effects and Receptor Selectivity in Human Isolated Bronchi

    1989 · 151 citations
  16. Comparison of the effects of epithelium removal and of an enkephalinase inhibitor on the neurokinin‐induced contractions of guinea‐pig isolated trachea

    1988 · 138 citations
  17. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study

    2019 · 136 citations
  18. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

    2018 · 135 citations
  19. Small airways diseases, excluding asthma and COPD: an overview

    2013 · 130 citations
  20. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

    2019 · 127 citations
  21. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases

    2019 · 124 citations
  22. mRNA expression of tachykinins and tachykinin receptors in different human tissues

    2004 · 122 citations
  23. Treatment of allergic rhinitis using mobile technology with real‐world data: The MASK observational pilot study

    2018 · 121 citations
  24. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis

    2023 · 118 citations
  25. A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis

    2014 · 115 citations
  26. Pharmacological Characterization of Olodaterol, a Novel Inhaled β2-Adrenoceptor Agonist Exerting a 24-Hour-Long Duration of Action in Preclinical Models

    2010 · 115 citations
  27. Peptides and histamine release from rat peritoneal mast cells

    1985 · 108 citations
  28. Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK ‐rhinitis study

    2017 · 105 citations
  29. The Role of Toll-Like Receptors in the Production of Cytokines by Human Lung Macrophages

    2018 · 105 citations
  30. Vascular Biology of the Isoprostanes

    2001 · 104 citations
  31. The expression and relaxant effect of bitter taste receptors in human bronchi

    2013 · 102 citations
  32. The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study

    2017 · 102 citations
  33. Allergen exposure chambers: harmonizing current concepts and projecting the needs for the future – an EAACI Position Paper

    2017 · 100 citations
  34. Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study

    2018 · 99 citations
  35. Clinical Pharmacokinetics and Pharmacodynamics of Desloratadine, Fexofenadine and Levocetirizine

    2008 · 95 citations
  36. Small airway impairment in moderate to severe asthmatics without significant proximal airway obstruction

    2013 · 93 citations
  37. Work productivity in rhinitis using cell phones: The MASK pilot study

    2017 · 91 citations
  38. Population pharmacokinetics of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass

    2013 · 88 citations
  39. Update on the roles of distal airways in COPD

    2011 · 86 citations
  40. Bitter Taste Receptors (TAS2Rs) in Human Lung Macrophages: Receptor Expression and Inhibitory Effects of TAS2R Agonists

    2019 · 86 citations
  41. Nasal response to substance P and methacholine in subjects with and without allergic rhinitis

    1988 · 85 citations
  42. Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study

    2018 · 85 citations
  43. Real-life assessment of the multidimensional nature of dyspnoea in COPD outpatients

    2016 · 84 citations
  44. Role of the N-terminal arginine in the histamine-releasing activity of substance P, bradykinin and related peptides

    1989 · 83 citations
  45. House dust mite sublingual immunotherapy is safe and appears to be effective in moderate, persistent asthma

    2014 · 83 citations
  46. A Practical Tranexamic Acid Dosing Scheme Based on Population Pharmacokinetics in Children Undergoing Cardiac Surgery

    2013 · 79 citations
  47. Update on the roles of distal airways in asthma

    2009 · 79 citations
  48. How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA2LEN statement

    2011 · 78 citations
  49. Imatinib assay by HPLC with photodiode-array UV detection in plasma from patients with chronic myeloid leukemia: Comparison with LC-MS/MS

    2009 · 78 citations
  50. Thromboxane A2and related prostaglandins in airways

    1997 · 77 citations

← Return to the university profile